Saturday, March 1, 2014

Cytotoxic Drug Development: Choose Your Partner Well


Choose Your Partner Well - Ask ABC


Although regulatory requirements are fundamentally the same for all investigational drugs, working with cytotoxic materials presents unique challenges. Heightened safety procedures and encumbering personal protective equipment can be a drag on timelines—or worse, lead to procedural or analytical errors that compromise data integrity. It's critical to choose a CRO with cytotoxic expertise, yet the field of competent outsourcing partners is small.

No comments:

Post a Comment